- Last edited on October 27, 2023
Differences
This shows you the differences between two versions of the page.
| Both sides previous revision Previous revision | Previous revision | ||
|
cl:2-major-neurocog-disorder [on March 20, 2019] |
cl:2-major-neurocog-disorder [on April 25, 2020] |
||
|---|---|---|---|
| Line 1: | Line 1: | ||
| - | ~~NOTOC~~ | ||
| ====== Major Neurocognitive Disorder ====== | ====== Major Neurocognitive Disorder ====== | ||
| + | {{INLINETOC}} | ||
| ===== Diagnostic Criteria ===== | ===== Diagnostic Criteria ===== | ||
| <WRAP group> | <WRAP group> | ||
| <WRAP half column> | <WRAP half column> | ||
| ==== Criterion A ==== | ==== Criterion A ==== | ||
| - | Evidence of **//significant//** cognitive decline from a previous level of performance in one or more cognitive domains (complex attention, executive function, learning and memory, language, perceptual-motor, or social cognition) based on: | + | Evidence of **//significant//** cognitive decline from a previous level of performance in ''1'' or more cognitive domains (complex attention, executive function, learning and memory, language, perceptual-motor, or social cognition) based on: |
| - Concern of the individual, a knowledgeable informant, or the clinician that there has been a significant decline in cognitive function; and | - Concern of the individual, a knowledgeable informant, or the clinician that there has been a significant decline in cognitive function; and | ||
| - A substantial impairment in cognitive performance, preferably documented by standardized neuropsychological testing or, in its absence, another quantified clinical assessment. | - A substantial impairment in cognitive performance, preferably documented by standardized neuropsychological testing or, in its absence, another quantified clinical assessment. | ||